Federated Hermes’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.66M Buy
1,080,712
+655,063
+154% +$5.44M 0.01% 747
2025
Q4
$4.44M Buy
425,649
+166,220
+64% +$1.67M 0.01% 806
2025
Q3
$2.33M Sell
259,429
-1,882
-0.7% -$16.5K ﹤0.01% 897
2025
Q2
$3.4M Buy
+261,311
New +$3.93M 0.01% 825
2025
Q1
Sell
-6,146
Closed -$211K 2183
2024
Q4
$211K Sell
6,146
-63,118
-91% -$2.85M ﹤0.01% 1476
2024
Q3
$3.42M Sell
69,264
-271,584
-80% -$13.9M 0.01% 810
2024
Q2
$20.5M Buy
340,848
+43
+0% +$2.46K 0.05% 395
2024
Q1
$17.6M Buy
340,805
+75,883
+29% +$3.72M 0.04% 442
2023
Q4
$10.7M Sell
264,922
-47,669
-15% -$1.4M 0.03% 547
2023
Q3
$8.72M Sell
312,591
-2,823
-0.9% -$84.2K 0.02% 567
2023
Q2
$9.08M Buy
+315,414
New +$7.02M 0.02% 564
2021
Q4
Sell
-510,000
Closed -$6.46M 2294
2021
Q3
$6.46M Buy
+510,000
New +$7.02M 0.01% 765

Other funds holding RXST

Federated Hermes's RXST Position: Q1 2026 in Review

Federated Hermes increased its RxSight (RXST) stake by 154% in Q1 2026, buying an estimated $5.44M and bringing the position to 1,080,712 shares worth $6.66M. The position accounts for 0.01% of the portfolio, ranked #747.

Federated Hermes first reported a position in RXST in Q3 2021 and has held it in 12 quarters since. The position peaked at $20.5M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Federated Hermes held 1,080,712 shares of RxSight worth $6.66M as of Q1 2026.
  • Federated Hermes bought 655,063 RxSight shares in Q1 2026, an estimated $5.44M.
  • RxSight made up 0.01% of Federated Hermes's portfolio in Q1 2026, its #747 holding.
  • Federated Hermes first reported a position in RxSight in Q3 2021 and has held it in 12 quarters since.
  • Federated Hermes's RxSight position peaked at $20.5M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.